Qualigen Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Faraday Future Intelligent Electric Inc. has increased its beneficial ownership in Qualigen Therapeutics, Inc. to 19.99% following the conversion of Series B Preferred Stock.
Faraday Future Intelligent Electric Inc. has acquired an 8.0% stake in Qualigen Therapeutics, Inc., initiating a strategic pivot towards cryptocurrency and significant governance changes.